170 related articles for article (PubMed ID: 36355361)
1. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3).
Girardi F; Matz M; Stiller C; You H; Marcos Gragera R; Valkov MY; Bulliard JL; De P; Morrison D; Wanner M; O'Brian DK; Saint-Jacques N; Coleman MP; Allemani C;
Neuro Oncol; 2023 Mar; 25(3):580-592. PubMed ID: 36355361
[TBL] [Abstract][Full Text] [Related]
2. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3).
Girardi F; Di Carlo V; Stiller C; Gatta G; Woods RR; Visser O; Lacour B; Tucker TC; Coleman MP; Allemani C;
Neuro Oncol; 2023 Mar; 25(3):593-606. PubMed ID: 36215122
[TBL] [Abstract][Full Text] [Related]
3. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).
Girardi F; Rous B; Stiller CA; Gatta G; Fersht N; Storm HH; Rodrigues JR; Herrmann C; Marcos-Gragera R; Peris-Bonet R; Valkov M; Weir HK; Woods RR; You H; Cueva PA; De P; Di Carlo V; Johannesen TB; Lima CA; Lynch CF; Coleman MP; Allemani C;
Neuro Oncol; 2021 Oct; 23(10):1765-1776. PubMed ID: 33738488
[TBL] [Abstract][Full Text] [Related]
4. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Allemani C; Matsuda T; Di Carlo V; Harewood R; Matz M; Nikšić M; Bonaventure A; Valkov M; Johnson CJ; Estève J; Ogunbiyi OJ; Azevedo E Silva G; Chen WQ; Eser S; Engholm G; Stiller CA; Monnereau A; Woods RR; Visser O; Lim GH; Aitken J; Weir HK; Coleman MP;
Lancet; 2018 Mar; 391(10125):1023-1075. PubMed ID: 29395269
[TBL] [Abstract][Full Text] [Related]
5. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
Ssenyonga N; Stiller C; Nakata K; Shalkow J; Redmond S; Bulliard JL; Girardi F; Fowler C; Marcos-Gragera R; Bonaventure A; Saint-Jacques N; Minicozzi P; De P; Rodríguez-Barranco M; Larønningen S; Di Carlo V; Mägi M; Valkov M; Seppä K; Wyn Huws D; Coleman MP; Allemani C;
Lancet Child Adolesc Health; 2022 Jun; 6(6):409-431. PubMed ID: 35468327
[TBL] [Abstract][Full Text] [Related]
6. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
[TBL] [Abstract][Full Text] [Related]
7. Population-based survival data for brain tumors in Korea.
Jung KW; Yoo H; Kong HJ; Won YJ; Park S; Lee SH
J Neurooncol; 2012 Sep; 109(2):301-7. PubMed ID: 22660961
[TBL] [Abstract][Full Text] [Related]
8. Population-based cancer survival in the United States: Data, quality control, and statistical methods.
Allemani C; Harewood R; Johnson CJ; Carreira H; Spika D; Bonaventure A; Ward K; Weir HK; Coleman MP
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):4982-4993. PubMed ID: 29205302
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
[TBL] [Abstract][Full Text] [Related]
12. The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.
Ward ZJ; Atun R; Hricak H; Asante K; McGinty G; Sutton EJ; Norton L; Scott AM; Shulman LN
Lancet Oncol; 2021 Sep; 22(9):1301-1311. PubMed ID: 34416159
[TBL] [Abstract][Full Text] [Related]
13. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000-2014 (CONCORD-3).
Nikšić M; Matz M; Valkov M; Marcos-Gragera R; Stiller C; Rosso S; Coleman MP; Allemani C;
Cancer Epidemiol; 2022 Oct; 80():102196. PubMed ID: 35841761
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
[TBL] [Abstract][Full Text] [Related]
16. Cancer survival in five continents: a worldwide population-based study (CONCORD).
Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
van den Bent MJ; Smits M; Kros JM; Chang SM
J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
[TBL] [Abstract][Full Text] [Related]
18. Global Trends in Survival From Astrocytic Tumors in Adolescents and Young Adults: A Systematic Review.
Girardi F; Allemani C; Coleman MP
JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa049. PubMed ID: 33134829
[TBL] [Abstract][Full Text] [Related]
19. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
20. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
